Pharmaceutical Business Development

Feb212016 by Pharmaceutical TechNo Comments

The Pivot of FDI in Indian Pharma

The department of industrial policy promotion (DIPP) is bringing new headwinds to the FDI (Foreign Direct Investment) in the sector of pharmaceuticals that looking for a review from it in regarding policies barely after its intervention from prime minister Clearance in months. The controversy rises here is regarding the FDI in retail to kick up the retail industry might bump back for time being, whereas another sector pharmaceuticals from FDI is quietly comes for UPA government clearance, which is going to hit common man pocket in future. States in India have some patent rights on the investor’s expenditure that spent on innovative research resources. These rights are granted for a certain period and during this period the owner solely can manufacture the drug by finding and fixing price...

Reasons Behind Pharmaceutical Industry to Focus on Loyalty

Economic and Regional Development, Pharma Industry, Pharmaceutical Business Development

For every industry maintaining relationship with the customers is the most benefitting factor and this is the reason behind adopting CRM for every industry. CRM for the pharmaceutical industry is one among those. Most of the companies are interested to automate their management process which helps to continuous engaging with their customers. CRM will help companies to get enduring relationship with customers and it is not only limited to existing customers, this also perfect platform to get connected with new customers. Marketing strategies of every company should change according to the current market conditions. Companies should focus on their market programs to turn into value oriented that would differentiate to get successful. Most importantly, leveraging customer loyalty is the ...

Patents: A Way of growth for Pharmaceutical Companies

Pharma Industry, Pharmaceutical Distribution and Logistics, Pharmaceutical Patenting, Pharmaceutical Purchasing, Pharmaceutical Quality Assurance

Recent developments in the pharma sector, triggering the concerns of cold wars amongst few companies pertaining to the patents for certain drugs, it only reflects as to how standard are our patenting laws, and what are the pro’s and con’s of the international patenting procedures of various countries, and how it implicates the growth of the Industry. In 2005, India has amended its Patent Act, to protect the interests of the patenting company. Grating a patent gives the company leverage to manufacturing and marketing of the product in exclusivity for a period of 20 years. Despite of amending the patent laws and the regulations, still the companies couldn’t come to terms with the prevailing conditions of the global market. It’s not a surprising factor, that today there are so many ...